14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Price (Quote)

$3.04
+0 (+0%)
At Close: Jan 22, 2018

Range Low Price High Price Comment
30 days $0.0060 $169.56 Monday, 22nd Jan 2018 ITEK stock ended at $3.04. During the day the stock fluctuated 0% from a day low at $3.04 to a day high of $3.04.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Inotek Pharmaceuticals Corporation prices

Date Open High Low Close Volume
Nov 08, 2017 $2.50 $2.59 $2.44 $2.58 126 337
Nov 07, 2017 $2.55 $2.57 $2.45 $2.48 168 732
Nov 06, 2017 $2.43 $2.58 $2.43 $2.55 160 348
Nov 03, 2017 $2.37 $2.55 $2.26 $2.40 459 707
Nov 02, 2017 $2.50 $2.56 $2.30 $2.39 309 345
Nov 01, 2017 $2.55 $2.59 $2.49 $2.52 327 644
Oct 31, 2017 $2.61 $2.65 $2.52 $2.52 426 190
Oct 30, 2017 $2.49 $2.70 $2.49 $2.58 330 778
Oct 27, 2017 $2.50 $2.53 $2.41 $2.53 363 404
Oct 26, 2017 $2.41 $2.50 $2.30 $2.47 515 136
Oct 25, 2017 $2.40 $2.49 $2.33 $2.43 266 896
Oct 24, 2017 $2.47 $2.54 $2.36 $2.41 437 877
Oct 23, 2017 $2.35 $2.65 $2.35 $2.47 948 345
Oct 20, 2017 $2.33 $2.44 $2.31 $2.38 491 913
Oct 19, 2017 $2.27 $2.59 $2.27 $2.33 1 324 829
Oct 18, 2017 $2.26 $2.40 $2.25 $2.30 563 251
Oct 17, 2017 $2.55 $2.62 $2.13 $2.22 1 295 324
Oct 16, 2017 $2.56 $2.77 $2.40 $2.59 1 494 265
Oct 13, 2017 $3.41 $3.80 $2.52 $2.74 15 208 175
Oct 12, 2017 $2.75 $2.98 $2.68 $2.95 1 217 305
Oct 11, 2017 $2.71 $2.82 $2.57 $2.77 766 428
Oct 10, 2017 $2.70 $2.95 $2.70 $2.75 1 053 812
Oct 09, 2017 $2.73 $2.74 $2.43 $2.66 968 235
Oct 06, 2017 $2.75 $3.19 $2.53 $2.62 4 486 381
Oct 05, 2017 $2.06 $3.55 $2.04 $3.03 11 875 390
Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT